학술논문

Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand
Document Type
Article
Source
In: Journal of Thrombosis and Haemostasis. (Journal of Thrombosis and Haemostasis, January 2024, 22(1):271-285)
Subject
Language
English
ISSN
15387836
15387933